Skip to main content
Journal cover image

De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype.

Publication ,  Journal Article
Shashi, V; Pena, LDM; Kim, K; Burton, B; Hempel, M; Schoch, K; Walkiewicz, M; McLaughlin, HM; Cho, M; Stong, N; Hickey, SE; Shuss, CM ...
Published in: Am J Hum Genet
October 6, 2016

The ASXL genes (ASXL1, ASXL2, and ASXL3) participate in body patterning during embryogenesis and encode proteins involved in epigenetic regulation and assembly of transcription factors to specific genomic loci. Germline de novo truncating variants in ASXL1 and ASXL3 have been respectively implicated in causing Bohring-Opitz and Bainbridge-Ropers syndromes, which result in overlapping features of severe intellectual disability and dysmorphic features. ASXL2 has not yet been associated with a human Mendelian disorder. In this study, we performed whole-exome sequencing in six unrelated probands with developmental delay, macrocephaly, and dysmorphic features. All six had de novo truncating variants in ASXL2. A careful review enabled the recognition of a specific phenotype consisting of macrocephaly, prominent eyes, arched eyebrows, hypertelorism, a glabellar nevus flammeus, neonatal feeding difficulties, hypotonia, and developmental disabilities. Although overlapping features with Bohring-Opitz and Bainbridge-Ropers syndromes exist, features that distinguish the ASXL2-associated condition from ASXL1- and ASXL3-related disorders are macrocephaly, absence of growth retardation, and more variability in the degree of intellectual disabilities. We were also able to demonstrate with mRNA studies that these variants are likely to exert a dominant-negative effect, given that both alleles are expressed in blood and the mutated ASXL2 transcripts escape nonsense-mediated decay. In conclusion, de novo truncating variants in ASXL2 underlie a neurodevelopmental syndrome with a clinically recognizable phenotype. This report expands the germline disorders that are linked to the ASXL genes.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Hum Genet

DOI

EISSN

1537-6605

Publication Date

October 6, 2016

Volume

99

Issue

4

Start / End Page

991 / 999

Location

United States

Related Subject Headings

  • Syndrome
  • Repressor Proteins
  • RNA, Messenger
  • Phenotype
  • Muscle Hypotonia
  • Megalencephaly
  • Male
  • Infant, Newborn
  • Infant
  • Hypertelorism
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shashi, V., Pena, L. D. M., Kim, K., Burton, B., Hempel, M., Schoch, K., … Kortüm, F. (2016). De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype. Am J Hum Genet, 99(4), 991–999. https://doi.org/10.1016/j.ajhg.2016.08.017
Shashi, Vandana, Loren D. M. Pena, Katherine Kim, Barbara Burton, Maja Hempel, Kelly Schoch, Magdalena Walkiewicz, et al. “De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype.Am J Hum Genet 99, no. 4 (October 6, 2016): 991–99. https://doi.org/10.1016/j.ajhg.2016.08.017.
Shashi V, Pena LDM, Kim K, Burton B, Hempel M, Schoch K, et al. De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype. Am J Hum Genet. 2016 Oct 6;99(4):991–9.
Shashi, Vandana, et al. “De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype.Am J Hum Genet, vol. 99, no. 4, Oct. 2016, pp. 991–99. Pubmed, doi:10.1016/j.ajhg.2016.08.017.
Shashi V, Pena LDM, Kim K, Burton B, Hempel M, Schoch K, Walkiewicz M, McLaughlin HM, Cho M, Stong N, Hickey SE, Shuss CM, Undiagnosed Diseases Network, Freemark MS, Bellet JS, Keels MA, Bonner MJ, El-Dairi M, Butler M, Kranz PG, Stumpel CTRM, Klinkenberg S, Oberndorff K, Alawi M, Santer R, Petrovski S, Kuismin O, Korpi-Heikkilä S, Pietilainen O, Aarno P, Kurki MI, Hoischen A, Need AC, Goldstein DB, Kortüm F. De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype. Am J Hum Genet. 2016 Oct 6;99(4):991–999.
Journal cover image

Published In

Am J Hum Genet

DOI

EISSN

1537-6605

Publication Date

October 6, 2016

Volume

99

Issue

4

Start / End Page

991 / 999

Location

United States

Related Subject Headings

  • Syndrome
  • Repressor Proteins
  • RNA, Messenger
  • Phenotype
  • Muscle Hypotonia
  • Megalencephaly
  • Male
  • Infant, Newborn
  • Infant
  • Hypertelorism